Upregulation of FOXP3+ Regulatory T Lymphocytes and CD8+ Lymphocytes in Patients with High-Grade Squamous Intraepithelial Lesions Correlated with HPV Infection

Bedell, S. L., Goldstein, L. S., Goldstein, A. R., Goldstein, A. T. (2020). Cervical cancer screening: Past, present, and future. Sex Med., 8 (1), 28–37.10.1016/j.sxmr.2019.09.00531791846 Search in Google Scholar

Bedoya, A. M., Jaramillo. R., Baena, A., Castano, J., Olaya, N., Zea, A. H., Herrero, R., Sanchez, G. I. (2013). Location and density of immune cells in precursor lesions and cervical cancer. Cancer Microenviron., 6 (1), 69–77.10.1007/s12307-012-0097-8360121522290207 Search in Google Scholar

Brenton, J. D., Ellenson, L. H., Gilks, C. B., Herrington, C. S. (2019). WHO Classification of Tumours. 5th edition. Vol. 4. WHO. Lyon, 632 pp. Search in Google Scholar

Brito, M. J., Sequeira, P., Silva, I., Quintas, A., Martins, C., Félix, A. (2021). CD4 + and CD8 + cell populations in HIV-positive women with cervical squamous intra-epithelial lesions and squamous cell carcinoma. Int. J. Infect. Dis., 103, 370–377.10.1016/j.ijid.2020.10.08333157285 Search in Google Scholar

Bonin, C. M., Padovani, C. T. J., da Costa, I. P, Ávila, L. S., Ferreira, A. M. T., Fernandes, C. E. S., Dos Santos, A. R., Tozetti, I. A. (2018). Detection of regulatory T cell phenotypic markers and cytokines in patients with human papillomavirus infection, J. Med. Virol., 91, 2, 317–325.10.1002/jmv.25312 Search in Google Scholar

Das, D., Sarkar, B., Mukhopadhyay, S., Banerjee, C., Biswas, S. M. (2018). An altered ratio of CD4+ and CD8+ T lymphocytes in cervical cancer tissues and peripheral blood — a prognostic clue? Asian Pac. J. Cancer Prev., 19 (2), 471. Search in Google Scholar

Gholami, D. M., Kardar, G. A., Saeedi, Y., Heydari, S., Garssen, J., Falak, R. (2017). Exhaustion of T lymphocytes in the tumor microenvironment: Significance and effective mechanisms. Cell Immunol., 322,1–14.10.1016/j.cellimm.2017.10.00229079339 Search in Google Scholar

Gurrola-Diaz, C. M., Suarez-Rincon, A. E., Vazquez-Camacho, G., Buonocunto-Vazquez, G., Rosales-Quintana, S., Wentzensen, N., von Knebel Doeberitz, M. (2008). P16INK4a immunohistochemistry improves the reproducibility of the histological diagnosis of cervical intraepithelial neoplasia in cone biopsies. Gynecol. Oncol., 111, 120–124.10.1016/j.ygyno.2008.06.03218692882 Search in Google Scholar

Guzm an-Olea, E., Bermu dez-Morales, V. H., Peralta-Zaragoza, O., Torres-Poveda, K., Madrid-Marina, V. (2012). Molecular mechanism and potential targets for blocking HPV-induced lesion development. J. Oncol., 20, 278312.10.1155/2012/278312 Search in Google Scholar

Kojima, S., Kawana, K., Tomio, K., Yamashita, A., Taguchi, A., Miura, S., Adachi, K., Nagamatsu, T., Nagasaka, K., Matsumoto, Y., et al. (2013). The prevalence of cervical regulatory T cells in HPV-related cervical intraepithelial neoplasia (CIN) correlates inversely with spontaneous regression of CIN. Amer. J. Reprod. Immunol., 69 (2), 134–141.10.1111/aji.1203023057776 Search in Google Scholar

Loddenkemper, C., Hoffmann, C., Stanke, J., Nagorsen, D., Baron, U., Olek, S., Huehn, J., Ritz, J. P., Stein, H., Kaufmann, A. M., Schneider, A., Cichon, C. (2009). Regulatory (FOXP3+) T cells as target for immune therapy of cervical intraepithelial neoplasia and cervical cancer. Cancer Sci., 100 (6), 1112–1117.10.1111/j.1349-7006.2009.01153.x19514119 Search in Google Scholar

Litwin, T. R., Irvin, S. R., Chornock, R. L., Sahasrabuddhe, V. V., Stanley, M., Wentzensen, N. (2021). Infiltrating T-cell markers in cervical carcinogenesis: A systematic review and meta-analysis. Brit. J. Cancer., 124 (4), 831–841.10.1038/s41416-020-01184-x788459233257839 Search in Google Scholar

Martin, C. M., O’Leary, J. J., Phil, D. (2011). Histology of cervical intraepithelial neoplasia and the role of biomarkers. Best Pract. Res. Clin. Obstet. Gynaecol., 25, 605–615.10.1016/j.bpobgyn.2011.04.005 Search in Google Scholar

Maskey, N., Thapa, N., Maharjan, M., Shrestha, G., Maharjan, N., Cai, H., Liu, S. (2019). Infiltrating CD4 and CD8 lymphocytes in HPV infected uterine cervical milieu. Cancer Manag Res., 14 (11), 7647-–7655.10.2147/CMAR.S217264669860431616181 Search in Google Scholar

Molina, M. A., Carosi Diatricch, L., Castany Quintana, M., Melchers, W. J., Andralojc, K. M. (2020). Cervical cancer risk profiling: Molecular biomarkers predicting the outcome of hrHPV infection. Expert Rev. Mol. Diagn., 20 (11), 1099–1120.10.1080/14737159.2020.183547233044104 Search in Google Scholar

Monnier-Benoit, S., Mauny, F., Riethmuller, D., Guerrini, J. S., Cãpîlna, M., Félix, S., Seillès, E., Mougin, C., Prétet, J. L. (2006). Immunohisto-chemical analysis of CD4+ and CD8+ T-cell subsets in high risk human papillomavirus-associated pre-malignant and malignant lesions of the uterine cervix. Gynecol Oncol., 102 (1), 22–31.10.1016/j.ygyno.2005.11.03916427684 Search in Google Scholar

Nguyen, H. H., Broker, T. R., Chow, L. T., Alvarez, R. D., Vu, H. L., Andrasi, J., Brewer, L. R., Jin, G., Mestecky, J. (2005). Immune responses to human papillomavirus in genital tract of women with cervical cancer. Gynecol Oncol., 96 (2), 452–461.10.1016/j.ygyno.2004.10.01915661235 Search in Google Scholar

Ostroumov, D., Fekete-Drimusz, N., Saborowski, M., Kühnel, F., Woller, N. (2018). CD4 and CD8 T lymphocyte interplay in controlling tumor growth. Cell Mol. Life Sci., 75, 689.10.1007/s00018-017-2686-7576982829032503 Search in Google Scholar

Øvestad, I. T., Gudlaugsson, E., Skaland, I., Malpica, A., Kruse, A. J., Janssen, E. A, Baak, J. P. (2010). Local immune response in the micro-environment of CIN2-3 with and without spontaneous regression. Mod. Pathol., 23 (9),1231–1240.10.1038/modpathol.2010.10920512116 Search in Google Scholar

Ozaki, S., Zen, Y., Inoue, M. (2011). Biomarker expression in cervical intraepithelial neoplasia: Potential progression predictive factors for low-grade lesions. Hum. Pathol., 42,1007–1012.10.1016/j.humpath.2010.10.02121315414 Search in Google Scholar

Shang, B., Liu, Y., Jiang, S. J., Liu, Y (2015). Prognostic value of tumor-infiltrating FoxP3+ regulatory T cells in cancers: a systematic review and meta-analysis. Sci Rep., 5,15179.10.1038/srep15179460447226462617 Search in Google Scholar

Shibata, T., Lieblong, B. J., Sasagawa, T., Nakagawa, M. (2019). The promise of combining cancer vaccine and checkpoint blockade for treating HPV-related cancer. Cancer Treatment Rev., 10, 1016.10.1016/j.ctrv.2019.07.001671012331302573 Search in Google Scholar

Schorge, J. O., Lea, J. S., Elias, K. J., Rajanbabu, R., Coleman, R. L., Miller, D. S., Ashfaq, R. (2004). p16 as a molecular biomarker of cervical adenocarcinoma. Amer. J. Obstet. Gynecol., 190, 668–673.10.1016/j.ajog.2003.09.03815041997 Search in Google Scholar

Tainio, K., Athanasiou, A., Tikkinen, K. A. O., Aaltonen, R., Cárdenas, J., Hernándes Glazer-Livson, S., Jakobsson, M., Joronen, K., Kiviharju, M., et al. (2018). Clinical course of untreated cervical intraepithelial neoplasia grade 2 under active surveillance: Systematic review and meta-analysis. Brit. Med. J., 360, k499.10.1136/bmj.k499582601029487049 Search in Google Scholar

Trifonova, R. T., Lieberman. J., van Baarle, D. (2014). Distribution of immune cells in the human cervix and implications for HIV transmission. Amer. J. Reprod. Immunol., 71 (3), 252–64.10.1111/aji.12198394353424410939 Search in Google Scholar

Van Niekerk, D., Guillaud, M., Matisic, J., Benedet, J. L., Freeberg, J. A., Follen, M., MacAulay, C. (2007). p16 and MIB1improve the sensitivity and specificity of the diagnosis of high grade squamous intraepithelial lesions: Methodological issues in a report of 447 biopsies with consensus diagnosis and HPV HCII testing. Gynecol. Oncol., 107, S233–240.10.1016/j.ygyno.2007.07.064 Search in Google Scholar

Vattai, A., Kremer, N., Meister, S., Beyer, S., Keilmann, L., Hester, A., Temelkov, M., Heidegger, H., Schmoeckel, E., Kessler, M., Mahner, S., Jeschke, U., Hertlein, L., Kolben, T. (2021). Role of FoxP3-positive regulatory T cells in regressive and progressive cervical dysplasia. J. Cancer Res. Clin. Oncol., 148 (2), 377–386. doi: 10.1007/s00432-021-03838-6.10.1007/s00432-021-03838-634739585 Search in Google Scholar

Weston, G., Dombrowski, C., Harvey, M. J., Iftner, T., Kyrgiou, M., Founta, C., Adams, E. J. (2020). Use of the Aptima mRNA high-risk human papillomavirus (HR-HPV) assay compared to a DNA HR-HPV assay in the English cervical screening programme: A decision tree model based economic evaluation. BMJ Open, 10 (3), e031303.10.1136/bmjopen-2019-031303706407132152154 Search in Google Scholar

Zheng, Hu., Ding, Ma. (2018). The precision prevention and therapy of HPV-related cervical cancer: New concepts and clinical implications. Cancer Med., 7 (10), 5217–5236.10.1002/cam4.1501 Search in Google Scholar

Yang, H., Ye, S., Goswami, S., Li, T., Wu, J., Cao, C., Ma, J., Lu, B., Pie, X., Chen, Y., Yu, J., Xu, H., Qiu, L., Afridi, S., Xiang, L., Zhang, X. (2020). Highly immunosuppressive HLADRhi regulatory T cells are associated with unfavorable outcomes in cervical squamous cell carcinoma. Int. J. Cancer, 146 (7), 1993–2006.10.1002/ijc.3278231709528 Search in Google Scholar